Clinical Pharmacology & Biopharmaceutics
Open Access

Nanomedicine in Oncology: Targeted Drug Delivery Systems for Precision Cancer Treatment

Diana Bolton^*

Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Austria

Received Date: Nov 01, 2024 / Published Date: Nov 29, 2024

Citation: Diana B (2024) Nanomedicine in Oncology: Targeted Drug Delivery Systems for Precision Cancer Treatment Clin Pharmacol Biopharm, 13: 511.

Copyright: © 2024 Diana B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF | Peer-reviewed Full Article

Nanomedicine has emerged as a transformative approach in oncology, enabling precise drug delivery and enhancing the therapeutic potential of cancer treatments. Targeted drug delivery systems (TDDS) in nanomedicine are designed to improve the bioavailability and therapeutic index of anti-cancer agents while minimizing off-target effects. These systems utilize nanoparticles, nanocarriers, and molecular targeting strategies to selectively deliver drugs to tumor cells, ensuring that high concentrations of therapeutic agents reach the site of action. This approach aims to overcome the limitations of conventional chemotherapy, such as poor solubility, systemic toxicity, and drug resistance. The development of advanced nanomaterials, such as liposomes, dendrimers, micelles, and nanorods, has enabled the creation of more effective and personalized treatment regimens. Additionally, the integration of targeting ligands, such as antibodies and peptides, further enhances the specificity and efficacy of these therapies. This review explores the current progress, challenges, and future prospects of nanomedicine-based targeted drug delivery systems in oncology, highlighting their role in precision cancer treatment.